
Sign up to save your podcasts
Or


To learn about pepteins, we had a conversation with Christian Schwarz, CEO and co-founder of Numaferm.
Numaferm is a German biotech company, specializing in the production of pepteins, which are an underdeveloped class of molecules located between peptides and proteins (with a length of 30-300 amino acids). Pepteins are non-structured and complex posing a challenge for manufacturing, yet exert a high biological activity, wherefore they play an increasing role as innovative molecules in a range of industries, including animal and human health.
To date, peptein production via chemical synthesis or recombinant approaches is cumbersome, leading to time and resource-intensive development programs. This, in combination with high production costs, limits promising peptein applications.
The proprietary high-titer expression platform Numaswitch changes this situation and enables the access to pepteins within weeks.
The company and Zoetis, an animal health company, recently signed a licensing agreement for the development and production of defined veterinary therapeutics.
By Labiotech3.3
33 ratings
To learn about pepteins, we had a conversation with Christian Schwarz, CEO and co-founder of Numaferm.
Numaferm is a German biotech company, specializing in the production of pepteins, which are an underdeveloped class of molecules located between peptides and proteins (with a length of 30-300 amino acids). Pepteins are non-structured and complex posing a challenge for manufacturing, yet exert a high biological activity, wherefore they play an increasing role as innovative molecules in a range of industries, including animal and human health.
To date, peptein production via chemical synthesis or recombinant approaches is cumbersome, leading to time and resource-intensive development programs. This, in combination with high production costs, limits promising peptein applications.
The proprietary high-titer expression platform Numaswitch changes this situation and enables the access to pepteins within weeks.
The company and Zoetis, an animal health company, recently signed a licensing agreement for the development and production of defined veterinary therapeutics.

43,673 Listeners

535 Listeners

2,707 Listeners

2,454 Listeners

123 Listeners

321 Listeners

62 Listeners

5,554 Listeners

86 Listeners

34 Listeners

522 Listeners

153 Listeners

15,906 Listeners

20 Listeners

95 Listeners